Donald S Burke, MD

• Bachelor of Arts Degree, Western Reserve University, Cleveland, Ohio, 1967 (chemistry major; honors in biology; magna cum laude; Phi Beta Kappa)
• Doctorate in Medicine, Harvard Medical School, Boston, Massachusetts, 1971
• Clinical Fellow in Medicine (Intern & Junior Resident Physician), Harvard University and the Boston City Hospital, Boston, Massachusetts, 1971-73
• Clinical Fellow in Medicine (Senior Resident Physician), Harvard University and the Massachusetts General Hospital, Boston, Massachusetts, 1975-76
• Research Fellow in Infectious Diseases, Walter Reed Army Medical Center, Washington, DC, 1976-78

• Certified, Diplomat in the Specialty of Internal Medicine, American Board of Internal Medicine, 1977
• Certified, Diplomat in the Sub-Specialty of Infectious Diseases, American Board of Internal Medicine, 1978
• Medical License, State of Maryland, through September 2012, with identification as a Specialist in Internal Medicine and in Infectious Diseases

2006-PRESENT

• Dean, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA
• Distinguished University Professor of Health Science and Policy, University of Pittsburgh, Pittsburgh, PA
• Associate Vice Chancellor for Global Health, University of Pittsburgh, Pittsburgh, PA

2006-2016

• Director, Center for Vaccine Research, University of Pittsburgh, Pittsburgh, PA

2002-2006

• Associate Department Chairman and Program Director, Disease Prevention and Control Program, Department of International Health, Johns Hopkins Bloomberg School of Public Health. Led 42 full time Disease Prevention and Control faculty. Elected by vote of the faculty in 2002, re-elected in 2005.

1997-2006

• Professor of International Health and Professor of Epidemiology, Johns Hopkins Bloomberg School of Public Health
• Professor of Medicine, Johns Hopkins School of Medicine
• Director, Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health
• Principal Investigator, Johns Hopkins Cameroon Program, 1998-2003
• Principal Investigator, Johns Hopkins HIV Vaccine Trials Unit (National Institutes of Health / NIAID, 1999-2006)
• Co-Principal Investigator, Mid-Atlantic Regional Center of Excellence for Biodefense (National Institutes of Health / NIAID, 2003-2006)
• Principal Investigator, “MIDAS” Modeling of Infectious Disease Agents Study (National Institutes of Health / NIGMS, 2004-2006)

1996-1997

• Associate Director for Emerging Threats and Biotechnology, Walter Reed Army Institute of Research (WRAIR), Washington, DC. Responsible for design and implementation of research programs on infectious diseases of military importance and new technologies in biomedicine. Coordinated global research activities on surveillance, diagnosis, prevention, and treatment of emerging infectious diseases. Retired from the US Army Medical Corps in 1997 as a Colonel after 23 years of active duty service.

1990-1996

• Director, US Military HIV/AIDS Research Program, Rockville, MD. A nation-wide Army, Navy, and Air Force cooperative effort aimed at controlling HIV/AIDS in military populations. Directly or indirectly supervised and coordinated activities of 50 doctoral level and 150 technical and administrative personnel. Served as Area Manager for HIV/AIDS Research, US Army Medical Research and Material Command, responsible for distribution and management of retrovirus research funds, which averaged $30 million per year. Emphasis on basic and applied research on HIV/AIDS vaccines.

1988-1990

• Director, Division of Retrovirology, WRAIR, Washington, DC
• Founder and Director, US Military HIV/AIDS Laboratory Complex, Rockville, Maryland. Responsible for design and conduct of US Military HIV/AIDS medical research studies, and for the management and direction of a 28,000 sq ft. laboratory complex of co-located Government, Jackson Foundation, and contractor facilities. Continued responsibilities for ongoing military HIV screening and medical staging programs.

1984-1988

• Chief, Department of Virus Diseases, WRAIR, Washington, DC. Responsible for the intramural research program on virus diseases of military importance, especially HIV/AIDS, flaviviruses, and hepatitis viruses. Responsible for the design and conduct of US military HIV screening and medical staging programs.

1978-1984

• Chief, Virology Department, Armed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand. Responsible for the design and conduct of research on tropical viruses of military importance, especially dengue and Japanese encephalitis viruses. Emphasis on studies related to vaccine development and testing. Also served as Deputy Director, AFRIMS, 1983-84.

1976-1978

• Clinical Desk Officer, Department of Virus Diseases, WRAIR. Responsible for diagnostic virology at Walter Reed Army Medical Center . Simultaneously fulfilled clinical responsibilities as an Infectious Disease Fellow.

1973-1975

• Clinical Ward Officer and Chief, Medical Division, US Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Maryland. Responsible for occupational health of research workers in the high containment laboratories at USAMRIID. Conducted studies on vaccines against infectious disease agents of military significance.

MEDICAL AND PUBLIC HEALTH SOCIETIES

• John Snow Award, American Public Health Association, Epidemiology Section, 2018
• Jonas Salk Chair in Population Health, University of Pittsburgh, 2018-present
• Fellow, American Society of Tropical Medicine & Hygiene, 2016
• Distinguished University Professor of Health Science and Policy, University of Pittsburgh, 2011
• Elected member, Institute of Medicine of the National Academies of Science, 2009
• Lifetime National Associate of the National Research Council for "Extraordinary Service to the NRC and the Academies", 2008
• Ambassador, Paul G. Rogers Society for Global Health Research, 2007
• UPMC-Jonas Salk Chair in Global Health, University of Pittsburgh, 2006-2018
• Elected Fellow, American Epidemiological Society, 2006
• Elected Fellow, American Association for the Advancement of Science (Medical Science), 2003
• Elected Fellow, American Academy of Microbiology, 2000
• Elected Member, Delta Omega Public Health Honorary Society, 2000
• Golden Apple Award (best teacher), Johns Hopkins School of Hygiene and Public Health, 1998-1999
• Elected President, American Society of Tropical Medicine & Hygiene, 1995-1996
• Sustaining Membership Award, Association of Military Surgeons of the US, for outstanding contributions to medical research, 1992
• Bailey K. Ashford Medal of the American Society of Tropical Medicine and Hygiene, for outstanding achievements in tropical medicine by a society member under the age of 45 years, 1990
• Kimble Methodology Award of the Conference of Public Health Laboratorians, for outstanding contributions to Public Health by development and implementation of HIV diagnostics, 1989
• Nathaniel A. Young Memorial Award of the American Committee on Arthropod-borne Viruses, American Society of Tropical Medicine and Hygiene, for outstanding contributions to arbovirology by a scientist under the age of 45 years, 1989

MILITARY HONORS

• Legion of Merit, 1997
• Meritorious Service Medal, Third Oak Leaf Cluster, 1991
• National Defense Service Medal, First Oak Leaf Cluster, 1991
• Department of the Army "A" Proficiency Designator, Infectious Diseases, 1990
• Order of Military Medical Merit, 1989
• Meritorious Service Medal, Second Oak Leaf Cluster, 1986
• Meritorious Service Medal, First Oak Leaf Cluster, 1985
• Overseas Ribbon, 1984
• Armed Forces Reserve Medal, 1984
• Humanitarian Service Medal, 1981
• Meritorious Service Medal, 1978
• Army Commendation Medal, 1975
• Army Service Ribbon, 1973
• National Defense Service Medal, 1973

SOCIETY MEMBERSHIP AND LEADERSHIP

• Chairman, Global Health Committee of the Association of Schools of Public Health
• Chairman, Pediatric Dengue Vaccine Initiative
• Elected Fellow, American Association for the Advancement of Science
• Elected Fellow, American Academy of Microbiology
• President (1995-96), American Society of Tropical Medicine and Hygiene
• Elected Fellow, American Epidemiological Society
• Fellow, Royal Society of Tropical Medicine and Hygiene (U.K.)
• Fellow, American College of Physicians
• Fellow, Infectious Disease Society of America
• Member, American Public Health Association
• Member, Physicians for Human Rights
• Member, American Society for Virology
• Member, American Association for the History of Medicine
• Member, International AIDS Society
• Member, International Society for Vaccines

CONSULTATIONS, PANELS AND BOARDS

• World Health Organization/SE Asia Regional Office, Temporary Advisor, on Research in Viral Hemorrhagic Fevers, 1980; on Dengue Hemorrhagic Fever, 1983; on Viral Hepatitis, 1984
• Steering Committee on Dengue Vaccines, World Health Organization, Member, 1985-1988
• Americans for a Sound AIDS Policy (ASAP) Advisory Council, Member, 1987-1992
• AIDS Vaccine Research and Development Subgroup, US Public Health Service, DoD representative, 1987-1992
• HIV Early Care Advisory Group, American Medical Association, Member, 1989-1990
• Diagnostic and Therapeutic Technology Assessment Panel, American Medical Association, Member, 1989-1991
• Roundtable for the Development of Drugs and Vaccines against AIDS, Institute of Medicine, Member, 1989-1994
• International Forum on AIDS Research, Institute of Medicine, Member, 1990-1992
• Steering Committee on AIDS/HIV Vaccine Development, World Health Organization, Member, 1991-1994
• HIV/AIDS Working Group, Center for Strategic and International Studies, Member, 1992-1994
• Mahidol University, Consultant, Post-graduate Training in Virology in Response to the HIV/AIDS Epidemic, Bangkok, Thailand, 1993
• Civil-Military Alliance Against HIV/AIDS, Co-Founder, 1993
• Working Group on HIV Vaccine Development and International Field Trials of the Federal Coordinating Committee on Science, Engineering and Technology Committee on Life Sciences and Health, Co-Chairman, 1992-1994
• Pharmaceutical Organization, Royal Thai Government, Consultant, on Local Production of HIV Vaccines, 1994
• AIDS Vaccine Trials Data and Safety Monitoring Board, Member, National Institutes of Health, 1988-1996
• UNAIDS, Temporary Advisor on HIV Molecular Epidemiology, 1996 and 2000
• Vice-President’s Working Group on HIV Vaccines and Therapeutics, White House, Member, 1996
• American Association of Blood Banks, Consultant, Think Tank on Emerging Viruses, 1996
• Ministry of Agriculture, Government of New Zealand, Consultant, on Rabbit Hemorrhagic Disease Virus as a Bio-control Agent, 1997
• National Institutes of Health Study Section on Tropical Medicine and Parasitology, Member, 1997-2000
• Food and Drug Administration, Transmissible Spongiform Encephalopathies Advisory Committee, Member, 1998-2002
• National Research Council, Panel on Climate, Ecology, Infectious Diseases, and Health, Chairman, 1999-2001
• Institute of Medicine, Department of Defense Global Emerging Infectious Surveillance Committee, Member, 2000-2001
• International Research Institute for Climate Prediction of Columbia University, Scientific Advisory Committee, Member, 2000-2003
• Institute of Medicine, Committee on Emerging Microbial Threats to Health in the 21st Century, Member, 2001-2003
• Smallpox Computational Modeling Working Group, Office of Public Health Emergency Preparedness, US Department of Health and Human Services, Member, 2002-2004
• SARS Task Force, Defense Science Board, Department of Defense, Member, 2003-2004
• National Biodefense Analysis and Countermeasure Center, Department of Homeland Security, Working Group on Threat Prioritization, Chair, Virology Group, 2003-2004
• Federation of American Scientists, Biosecurity Education for Biology Graduate Students Project, Temporary Advisor, 2004
• International AIDS Vaccine Initiative, Co-founder, 1994-96; Senior Scientific Advisor, 1997-2002; Policy Advisory Board Member, 2003-present
• Institute of Medicine, Department of Defense/Veterans Affairs Medical Follow-up Agency, Member of the Board, 2002-2006
• Physicians for Human Rights/Health Action AIDS, Executive Committee, 2003-present
• Data Safety and Monitoring Board, HIV Phase III Clinical Trial (Rayong Thailand), Member, 2004-present
• Consortium for Conservation Medicine, Executive Committee, 2004-present
• Bill & Melinda Gates Foundation, Technical Review Panel, HIV/AIDS Vaccines, Member, 2005
• Special Review Panel of the Joint National Institutes of Health / National Science Foundation Ecology of Infectious Disease Program, Panel Chairman, 2005
• Jewish Healthcare Foundation, Board Member, 2006-present
• Community Health Committee of the UPMC Board of Directors, 2006-present
• National Biodefense Analysis & Countermeasures Center, Science & Technology Advisory Committee, 2006-present
• NSF IGERT Sociotechnical Systems Advisory Board, 2006
• Welcome Trust/Bill & Melinda Gates Foundation Ad Hoc Advisory Meeting on Innovation in Research, Delegate, London, 2007
• Pediatric Dengue Vaccine Initiative, Board of Counselors, 2007-present
• UPMC Community Health Committee Board of Directors, 2007-present
• UPMC International Medical and Scientific Advisory Board 2007-present
• Pittsburgh Regional Health Initiatives Board of Directors, 2007-present
• Institute of Medicine, Health Sciences Policy Board Member, 2008-present
• Jewish Health Care Pittsburgh Regional Health Initiative (PRHI) Oversight Committee Member, 2008-2018
• Institute of Medicine, Board on Global Health to Research Needs for Retention of Variola Virus, Member, 2008-present
• Middle Atlantic Regional Center of Excellence (MARCE) Biosafety and Biocontainment Policies Committee Member, 2008-present
• NIH Director's Blue Ribbon Panel for the Risk Assessment of the National Emerging Infectious Diseases Laboratories, Member, 2008-present
• University of Pittsburgh Confucius Institute Advisory Board Member, 2008-present
• MRC Centre for Outbreak Analysis and Modeling Scientific Advisory Board Member, 2008-present
• Dengue Vaccine Advocacy Initiative (Sanofi-Pasteur) Steering Committee Member, 2008-present
• Pennsylvania Tobacco Use Prevention and Cessation Advisory Board Member, 2008-present
• UPMC/21CB Vaccine Production Steering Committee Member, 2009-present
• Institute of Medicine Report on Personal Protective Equipment against H1N1 Review Coordinator, 2009-present
• Pennsylvania's Public Health Law Advisory Committee, 2009-present

PUBLIC TESTIMONIES

• “Quality Control of HIV Screening,” Subcommittee on Regulation and Business Opportunities, House Small Business Committee, Quality Control of HIV Screening,” Subcommittee on Regulation and Business Opportunities, House Small Business Committee, US Congress, 19 October 1987
• “Obstacles to Routine Early Diagnosis of HIV,” Subcommittee on Health and the Environment, House Energy and Commerce Committee, US Congress, 4 April 1989
• “Progress on the Army’s HIV Research Program,” Subcommittee on Health and the Environment, House Energy and Commerce Committee, US Congress, 16 April 1991
• “Opportunities in AIDS Research,” Subcommittee on Health and the Environment, House Energy and Commerce Committee, US Congress, 24 April 1992
• “HIV Research in the US Military,” Subcommittee on Defense Technology, Acquisition, and Industrial Base, Senate Armed Services Committee, US Congress, 24 June 1993
• “Tropical Infectious Disease Research Funding,” Subcommittee on Foreign Operations, Export Financing, and Related Programs, House Committee on Appropriations, US Congress, 31 March 1998
• “Tropical Infectious Disease Research Funding,” Subcommittee on Defense, Senate Committee on Appropriations, US Congress, 11 May 1998
• "Infectious Disease Research," Subcommittee on Defense, Senate Committee on Appropriations, US Congress, 29 March 2000
• “Tropical Infectious Diseases” Subcommittee on Foreign Operations, Export Financing, and Related Programs, House Committee on Appropriations, US Congress, 2 April 2003

MEDICAL JOURNALS

EDITORIAL BOARD MEMBER

• AIDS Research and Human Retroviruses, 1987-1989
• Journal of Acquired Immune Deficiency Syndromes, 1988-1998
• American Journal of Tropical Medicine and Hygiene, 1988-1997
• Biosecurity and Bioterrorism, 2002-present
• Epidemics, 2008-present

EDITORIAL ADVISORY BOARD MEMBER

• Current Opinions in Infectious Diseases, Section Editor on HIV and AIDS, 1993
• Global Change and Human Health, 2000-2002
• Emerging Infectious Diseases, 1997-present
• Journal of Infectious Diseases, 2008-present

COLUMNIST

• AIDS and Society: International Research and Policy Bulletin, “Vaccine Watch” quarterly column, 1992-1994

EDITORIAL COMMITTEE

• Epidemiological Reviews, Vaccines and Public Health, 2005-2006 National Academies Reports

NATIONAL ACADEMIES REPORTS

NATIONAL RESEARCH COUNCIL, BOARD ON ATMOSPHERIC SCIENCES AND CLIMATE

• Chairman, Committee on Climate, Ecosystems, Infectious Diseases, and Human Health, 1999-2001
• Issued report entitled “Under the Weather: Climate, Ecosystems, and Infectious Disease,” 2001

NATIONAL RESEARCH COUNCIL, POLICY AND GLOBAL AFFAIRS COMMITTEE

• Reviewer, Report on “Future Contributions of the Biosciences to Public Health, Agriculture, Basic Research, Counter-terrorism, and Non-Proliferation Activities in Russia,” 2004

NATIONAL RESEARCH COUNCIL, BOARD ON LIFE SCIENCES

• Review Coordinator, report on “Exploring the role of antiviral drugs in the eradication of polio,” 2006

INSTITUTE OF MEDICINE, MEDICAL FOLLOW-UP AGENCY

• Member, Committee to Review the Department of Defense Global Emerging Infections Surveillance and Response System, 2000-2001. Issued report entitled “Perspectives on the Department of Defense Global Emerging Infections Surveillance and Response System: A Program Review,” 2001
• Reviewer, Report on “Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military,” 2002
• Medical Follow-up Agency Board Member, 2002-2006
• Member, Committee on Long-term Health Effects of Participation in Project SHAD, 2003-2006. Report in preparation.

INSTITUTE OF MEDICINE, BOARD ON GLOBAL HEALTH

• Member, Committee on Emerging Microbial Threats to Health in the 21 st Century, 2001-2003. Issued report entitled “Microbial Threats to Health: Emergence, Detection, and Response,” 2003
• Reviewer, Report on “Human Resources at U.S. Ports of Entry to Protect the Public's Health” (Interim Letter Report), 2004
• Member, Committee on Assessment of Future Scientific Needs for Live Variola Virus, 2008-present

INSTITUTE OF MEDICINE, BOARD ON HEALTH PROMOTION AND DISEASE PREVENTION

• Reviewer, Report on “ Gulf War and Health: Updated Literature Review of Sarin,” 2004
• Co-Chairman, Committee on Development of Reusable Facemasks for Use during an Influenza Pandemic. Issued report entitled “Facing the Flu: Reusability of Facemasks during an influenza pandemic,” 2006

ACADEMIC AND MEDICAL APPOINTMENTS/U.S. MILITARY

WALTER REED ARMY MEDICAL CENTER, WASHINGTON, DC

• Attending Physician, Infectious Diseases Service, 1985-1990
• Staff Physician, Department of Medicine, 1985-1997

U.S. ARMY COMMAND AND GENERAL STAFF COLLEGE, FORT LEAVENWORTH, KANSAS

• Faculty, Pre-Command Course, 1990-1992

UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES, BETHESDA, MARYLAND

• Adjunct Associate Professor, Department of Preventive Medicine/Biometrics, 1985-1992
• Associate Professor, Department of Medicine, 1987-1992
• Professor, Department of Medicine, 1992-1997

 VISITING PROFESSORSHIPS AND HONORARY LECTURES

• O. Ray Kling Distinguished Lecturer, Public Health Grand Rounds, University of Oklahoma, Oklahoma City, Oklahoma, 8 April 2009
• Keynote Address, Tulane University President's Symposium, New Orleans, Louisiana, 5 December 2008
• Invited Lecturer, "Science with the Stars", Walter Reed Army Institute of Research Seminar Series, Silver Springs, Maryland, 16 June 2008
• Keynote Address, Institute of Medicine Forum on Microbial Threats, Washington, DC, 4 December 2007
• Keynote Address, Annual Meeting of the US Department of Defense Global Emerging Infection Surveillance and Response System, Louisville, Kentucky, 6 August 2007
• John C. Cutler Memorial Lecturer, University of Pittsburgh Graduate School of Public Health, 26 September 2006 Chapman
• Keynote Address, Annual Symposium, New York Academy of Medicine and the Royal Society of Medicine, New York, New York, 13 June 2005
• Invited Lecturer, Annual Meeting of the National Academy of Sciences, Washington DC, 20 April 2004
• Centennial Anniversary Lecturer, American Society of Tropical Medicine and Hygiene, Philadelphia, Pennsylvania, 3 December 2003
• Distinguished Scientist Seminar, Marine Biological Laboratory, Woods Hole, Massachusetts, 8 November 2002
• Thomas Francis, Jr. Annual Memorial Lecturer, University of Michigan School of Public Health, Ann Arbor, Michigan, 28 March 2001
• Invited Lecturer, 50 th Anniversary Celebration of the University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, 19 February 1999
• Binford Memorial Lecturer, American Society of Microbiology, Atlanta, Georgia, 9 November 1997
• Presidential Address, American Society of Tropical Medicine and Hygiene, Baltimore, Maryland, 3 December 1996
• University of Pittsburgh School of Medicine, Department of Molecular Genetics and Biochemistry, Visiting Professor, 1-2 May 1995
• Harvard Medical School, Department of Microbiology and Molecular Genetics, Visiting Lecturer, 28 February 1995
• Tulane University School of Public Health and Tropical Medicine, Visiting Professor, 1-3 March 1994
• Dartmouth Medical School and Dartmouth College, Visiting Professor, 15-16 April 1993

INVITED LECTURES ON THE HISTORY OF MICROBIOLOGY AND VACCINES.

Some examples:

• Jesse Lazear of Hopkins: The First Fallen Yellow Fever Hero. Tropical Medicine Dinner Club of Baltimore, Baltimore, Maryland, 8 November 2000
• Malaria Research at Johns Hopkins, 1884 – 1897. Banquet Speaker, Inaugural Meeting of the Johns Hopkins Malaria Institute, Baltimore, Maryland, 27 January 2002
• History of the American Society of Tropical Medicine and Hygiene, 1903-2003. Centennial Celebration Plenary Address, ASTMH, Philadelphia, Pennsylvania, 3 December 2003
• Why Was West Nile Virus Originally Isolated?: Events leading to the virus isolation in Uganda in 1937. Invited Lecture, International Congress of Tropical Medicine and Malaria, Marseille, France, 14 September 2005
• Historical Perspective of Chikungunya Virus Epidemiology and Outbreaks. Invited Lecture, American Society of Tropical Medicine and Hygiene, Washington DC, 15 December 2005
• Serve as Archivist for the American Society of Tropical Medicine and Hygiene and the American Committee on Arthropod-borne Viruses, 1998 – present Languages
• Thai: Certificate of Literacy (reading and writing), Royal Thai Government, 1983
• French: Fair reading, writing, and speaking abilities

• Burke DS. Six Months to Act (Op-Ed on SARS). Wall Street Journal, 25 April 2003 (2003)
• Burke DS. Ignoring Deadly Viruses (Op-Ed on avian influenza). Asian Wall Street Journal, 26 January 2004 (2004)
• Burke DS. Avian Influenza Is a Threat To Our Collective Security (Op-Ed). Wall Street Journal, 3 November 2005 (2005)
• Burke DS. Forecasting the opioid epidemic (Op-Ed). Science, 4 November 2016 (2016)

• Center for Global Health 
• Center for Vaccine Research

From 2006 through June 2019, Donald S. Burke served as dean of the Graduate School of Public Health and associate vice chancellor for global health at the University of Pittsburgh, making him the longest-serving dean in school history. He is also the first occupant of the Jonas Salk Chair in Population Health and a distinguished university professor of health science and policy.
 

A native of Cleveland, Ohio, Burke received his BA from Western Reserve University and his MD from Harvard Medical School. He trained in medicine at Boston City and Massachusetts General Hospitals and in infectious diseases at the Walter Reed Army Medical Center. He served 23 years on active duty in the U.S. Army where he conducted research on the prevention of diseases of military importance.
 

Throughout his professional life, Burke has studied prevention and control of infectious diseases of global concern, including HIV/AIDS, influenza, dengue, and emerging infectious diseases. He has lived six years in Thailand, worked extensively in Cameroon, and conducted field epidemiology and vaccine studies in numerous other developing countries. He has approached epidemic control using strategies “from the bench to the bush.” He has authored or co-authored over 300 peer-reviewed academic publications.
 

He now leads a trans-disciplinary team that develops computational models and simulations of epidemic infectious and chronic diseases and uses these simulations to evaluate prevention and control strategies. He currently serves on the Board of Health for Allegheny County (Pittsburgh). Burke is a Fellow of the American Association for the Advancement of Science, the American Academy of Microbiology, and the American Epidemiological Society, and he is an elected member of the National Academy of Medicine.

van Panhuis WG, Cross A, Burke DS. Project Tycho 2.0: A repository to improve the integration and reuse of data for global population health. J Am Med Inform Assoc. 2018 Oct 15. doi:
10.1093/jamia/ocy123. [Epub ahead of print] PMID: 30321381 

Jalal H, Buchanich JM, Roberts MS, Balmert LC, Zhang K, Burke DS. Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016. Science. 2018 Sep 21;361(6408). pii: eaau1184. doi: 10.1126/science.aau1184.PMIC:30237320.

Espana G, Grefenstette J, Perkins A, Torres C, Campo Carey A, Diaz H, de la Hoz F, Burke DS, van Panhuis WG. Exploring scenarios of chikungunya mitigation with a data-driven agent-based model of the 2014-2016 outbreak in Colombia. Sci Rep. 2018 Aug 15;8(1):12201. doi:10.1038/x41598-018-30647-8. PMID:30111778; PMCID:PMC6093909.

Buchanich JM, Balmert LC, Williams KE, Burke DS. The effect of incomplete death certificates on estimates of unintentional opioid-related overdose deaths in the United States, 1999-2015. Public Health Rep. 2018 Jul/Aug;133(4):423-431. PMID:29945473 doi: 10.1177/0033354918774330.

Buchanich JM, Doerfler SM, Lann MF, Marsh GM, Burke DS. Improvement in racial disparities in years of life lost in the USA since 1990. PLoS One. 2018 Apr25;13(4):e0194308. PMID:29694402 doi:10.1371/journal.pone.0194308.

Nascimento EJM, Huleatt JW, Cordeiro MT, Castanha PMS, George JK, Grebe E, Welte A, Brown M, Burke DS, Marques ETA. Development of antibody biomarkers of long term and recent dengue virus infections. J Virol Methods, 2018 Jul;257:62-68. PMID:29684416. doi:10.1016/j.jviromet.2018.04.009.

Marques ETA, Burke DS. Tradition and innovation in development of a Zika vaccine. Lancet, 2018 Feb 10:391(10120):516-517. PMID:29217377. doi:10.1016/S0140-6736(17)33107-0.

Farrow DC, Brooks LC, Hyun S, Tibshirani RJ, Burke DS, Rosenfeld R. A human judgment approach to epidemiological forecasting. PLoS Comput Bio, 2017 Mar 10;13(3):e1005248. PMID:28282375. PMCID:PMC5345757. doi:10.1371/journal.pci.1005248.

Burke DS. Forecasting the opioid epidemic. Science. 2016 Nov 4;354(6312):529. PMID:27811241. doi:10.1126/science.aa12943.

Zimmerman RK, Nowalk MP, Chung J, Jackson ML, Jackson LA, Petrie JG, Monto AS, McLean HQ, Belongia EA, Gaglani M, Murthy K, Fry AM, Flannery B; U.S. Flu VE Investigators. 2014-2015 Influenza Vaccine Effectiveness in the United States by vaccine type. Clin Infect Dis. 2016 Dec 15;63(12):1564-1573. PMID:27702768. PMCID:PMC5146719. doi:10.1093/cid/ciw635.

Gearhart TL, Montelaro RC, Schurdak ME, Pilcher CD, Rinaldo CR, Kodadek T, Park Y, Islam K, Yurko R, Marques ET Jr, Burke DS. Selection of a potential diagnostic biomarker for HIV infection from a random library of non-biological synthetic peptoid oligomers. J Immunol Methods. 2016 Aug;435:85-89. PMID:27182050. PMCID:PMC4947968. doi:10.1016/j.jim.2016.05.001.

Buchanich JM, Balmert LC, Pringle JL, Williams KE, Burke DS, Marsh GM,. Patterns and trends in accidental poisoning death rates in the US, 1979-2014. Preventive Medicine. 2016 Apr 13. PMID:27085991. doi:10.1016/j.ypmed.2016.04.007.

Metcalf CJE, Farrar J, Cutts F, Basta N, Graham AL, Lessler J, Ferguson N, Burke D, Grenfell BT. Use of Serological surveys to generate key insights of the changing global landscape of infectious disease. Lancet. 2016 Aug 13:388(10045):728-30. doi:10.1016/S0140-6736(16)30164-7. Epub 2016 Apr 5. PMID:27059886

Balmert LC, Buchanich JM, Pringle JL, Williams KE, Burke DS, Marsh GM. Patterns and Trends in Accidental Poisoning Deaths: Pennsylvania's Experience 1979-2014. PLoS One. 2016;11(3):e0151655. doi:10.1371/journal.pone.0151655. PMID:26963396.

Dalziel BD, Bjørnstad ON, van Panhuis WG, Burke DS, Metcalf CJ, Grenfell BT. Persistent Chaos of Measles Epidemics in the Prevaccination United States Caused by a Small Change in Seasonal Transmission Patterns. PLoS Computational Biology. 2016 Feb;12(2):e1004655. doi:10.1371/journal.pcbi.1004655. PMID:26845437. PMCID:PMC4741526.

van Panhuis WG, Choisy M, Xiong X, Chok NS, Akarasewi P, Iamsirithaworn S, Lam SK, Chong CK, Lam FC, Phommasak B, Vongphrachanh P, Bouaphanh K, Rekol H, Hien NT, Thai PQ, Duong TN, Chuang JH, Liu YL, Ng LC, Shi Y, Tayag EA, Roque VG Jr, Lee Suy LL, Jarman RG, Gibbons RV, Velasco JM, Yoon IK, Burke DS, Cummings DA. Region-wide synchrony and traveling waves of dengue across eight countries in Southeast Asia. Proc Natl Acad Sci U S A. 2015 Oct 20;112(42):13069-74. doi: 10.1073/pnas.1501375112. Epub 2015 Oct 5.2015 Oct 5. PMID:26438851

Rodriguez-Barraquer I, Mier-y-Teran-Romero L, Ferguson N, Burke DS, Cummings DA.
Differential efficacy of dengue vaccine by immune status.
Lancet. 2015 May 2;385(9979):1726. doi: 10.1016/S0140-6736(15)60889-3. No abstract available. PMID:25943936

Farrow DC, Burke DS, Rosenfeld R.
Computational Characterization of Transient Strain-Transcending Immunity against Influenza A.
PLoS One. 2015 May 1;10(5):e0125047. doi: 10.1371/journal.pone.0125047. eCollection 2015.PMID:25933195

Ruberto I, Marques E, Burke DS, Van Panhuis WG.
The availability and consistency of dengue surveillance data provided online by the World Health Organization.
PLoS Negl Trop Dis. 2015 Apr 14;9(4):e0003511. doi: 10.1371/journal.pntd.0003511. eCollection 2015 Apr.PMID:25874804 

van Panhuis WG, Paul P, Emerson C, Grefenstette J, Wilder R, Herbst AJ, Heymann D, Burke DS.
A systematic review of barriers to data sharing in public health.
BMC Public Health. 2014 Nov 5;14:1144. doi: 10.1186/1471-2458-14-1144.PMID:25377061

Lukens S, DePasse J, Rosenfeld R, Ghedin E, Mochan E, Brown ST, Grefenstette J, Burke DS, Swigon D, Clermont G.
A large-scale immuno-epidemiological simulation of influenza A epidemics.
BMC Public Health. 2014 Sep 29;14:1019. doi: 10.1186/1471-2458-14-1019.PMID:25266818

LeBreton M, Switzer WM, Djoko CF, Gillis A, Jia H, Sturgeon MM, Shankar A, Zheng H, Nkeunen G, Tamoufe U, Nana A, Le Doux Diffo J, Tafon B, Kiyang J, Schneider BS, Burke DS, Wolfe ND.
A gorilla reservoir for human T-lymphotropic virus type 4.
Emerg Microbes Infect. 2014 Jan;3(1):e7. doi: 10.1038/emi.2014.7. Epub 2014 Jan 22.PMID:26038495

van Panhuis WG, Grefenstette J, Jung SY, Chok NS, Cross A, Eng H, Lee BY, Zadorozhny V, Brown S, Cummings D, Burke DS.
Contagious diseases in the United States from 1888 to the present.
N Engl J Med. 2013 Nov 28;369(22):2152-8. doi: 10.1056/NEJMms1215400. No abstract available. PMID:24283231

Rodriguez-Barraquer I, Mier-y-Teran-Romero L, Schwartz IB, Burke DS, Cummings DA.
Potential opportunities and perils of imperfect dengue vaccines.
Vaccine. 2014 Jan 16;32(4):514-20. doi: 10.1016/j.vaccine.2013.11.020. Epub 2013 Nov 19.PMID:24269318

Azman AS, Stark JH, Althouse BM, Vukotich CJ Jr, Stebbins S, Burke DS, Cummings DA.
Household transmission of influenza A and B in a school-based study of non-pharmaceutical interventions.
Epidemics. 2013 Dec;5(4):181-6. doi: 10.1016/j.epidem.2013.09.001. Epub 2013 Sep 26.PMID:24267874

Yonas MA, Burke JG, Brown ST, Borrebach JD, Garland R, Burke DS, Grefenstette JJ.
Dynamic simulation of crime perpetration and reporting to examine community intervention strategies.
Health Educ Behav. 2013 Oct;40(1 Suppl):87S-97S. doi: 10.1177/1090198113493090.PMID:24084404

Rodriguez-Barraquer I, Mier-y-Teran-Romero L, Burke DS, Cummings DA.
Challenges in the interpretation of dengue vaccine trial results.
PLoS Negl Trop Dis. 2013 Aug 29;7(8):e2126. doi: 10.1371/journal.pntd.0002126. eCollection 2013. No abstract available. PMID:24009782

Gibbons RV, Nisalak A, Yoon IK, Tannitisupawong D, Rungsimunpaiboon K, Vaughn DW, Endy TP, Innis BL, Burke DS, Mammen MP Jr, Scott RM, Thomas SJ, Hoke CH Jr.
A model international partnership for community-based research on vaccine-preventable diseases: the Kamphaeng Phet-AFRIMS Virology Research Unit (KAVRU).
Vaccine. 2013 Sep 23;31(41):4487-500. doi: 10.1016/j.vaccine.2013.07.082. Epub 2013 Aug 8. Review.PMID:23933334

Burke DS, Grefenstette JJ.
Toward an integrated meta-model of public health dynamics for preparedness decision support.
Public Health Manag Pract. 2013 Sep-Oct;19 Suppl 2:S12-5. doi: 10.1097/PHH.0b013e31828a842f. No abstract available. PMID:23903387

Reich NG, Shrestha S, King AA, Rohani P, Lessler J, Kalayanarooj S, Yoon IK, Gibbons RV, Burke DS, Cummings DA.
Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity.
J R Soc Interface. 2013 Jul 3;10(86):20130414. doi: 10.1098/rsif.2013.0414. Print 2013 Sep 6. PMID:23825116

Kumar S, Grefenstette JJ, Galloway D, Albert SM, Burke DS.
Policies to reduce influenza in the workplace: impact assessments using an agent-based model.
Am J Public Health. 2013 Aug;103(8):1406-11. doi: 10.2105/AJPH.2013.301269. Epub 2013 Jun 13.PMID:23763426

Toner ES, Adalja AA, Nuzzo JB, Inglesby TV, Henderson DA, Burke DS.
Assessment of serosurveys for H5N1.
Clin Infect Dis. 2013 May;56(9):1206-12. doi: 10.1093/cid/cit047. Epub 2013 Feb 5. PMID:23386633

Ma D, Jasinska A, Kristoff J, Grobler JP, Turner T, Jung Y, Schmitt C, Raehtz K, Feyertag F, Martinez Sosa N, Wijewardana V, Burke DS, Robertson DL, Tracy R, Pandrea I, Freimer N, Apetrei C; International Vervet Research Consortium.
SIVagm infection in wild African green monkeys from South Africa: epidemiology, natural history, and evolutionary considerations.
PLoS Pathog. 2013 Jan;9(1):e1003011. doi: 10.1371/journal.ppat.1003011. Epub 2013 Jan 17.PMID:23349627